NT5C1A and inclusion body myositis: The distinct subgroup of sporadic inclusion body myositis (IBM) was recognized, characterized by specific clinical features and the presence of endomysial auto-aggressive inflammation and muscle fiber vacuoles and amyloid deposits [4], as well as the frequent presence of anti-cytosolic 5′–nucleotidase 1A (CN1A) autoantibodies [5].